Triple combination immunotherapy with GVAX, anti-PD-1 monoclonal antibody, and agonist anti-OX40 monoclonal antibody is highly effective against murine intracranial glioma

Single-agent immunotherapy, including with immune checkpoint inhibition with anti-PD-1 antibody, has not extended survival in patients with malignant glioma. However, PD-1 inhibition may still play a role in combination immunotherapy with multiple agents. In this study, we evaluated anti-PD-1 antibo...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncoimmunology
Glavni autori: Jahan, Nusrat, Talat, Hammad, Alonso, Andrea, Saha, Dipongkor, Curry, William T.
Format: Artigo
Jezik:Inglês
Izdano: Taylor & Francis 2019
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6492981/
https://ncbi.nlm.nih.gov/pubmed/31069135
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2019.1577108
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items